Damora Therapeutics, Inc. Common Stock (DMRA)

$21.34 +5.83%

EARNINGS ANALYTICS

Damora Therapeutics, Inc. Common Stock (DMRA) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +53.04% (Jan 06, 2023) and its biggest decline was -9.44% (Mar 10, 2026).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±31.24%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Mar 10, 2026	☀ PRE	$27.93	$27.93	$25.51	9,696	-9.44%	open_in_new
Jan 06, 2023	☀ PRE	$1.51	$1.76	$1.76	650	+53.04%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±31.24%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G/A

2 chevron_right

description SCHEDULE 13G

1 chevron_right

Recent SEC Filings

3 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov

Frequently asked about DMRA earnings

How much does DMRA stock move after earnings? expand_more

Over 2 reports, DMRA has moved an average of ±31.24% the session after earnings, closing higher 50.0% of the time.

What was DMRA's biggest post-earnings move? expand_more

DMRA's largest post-earnings gain on record was +53.04% on Jan 06, 2023, and its largest decline was -9.44% on Mar 10, 2026.

Where can I find Damora Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Damora Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.